United Therapeutics | UTHR - Pasivo Circulante





Pasivo Circulante Cambio Fecha
Amarin USD 175.14M 10.94M 2026-09
Ardelyx USD 127.8M 4.42M 2026-09
Baxter International USD 3.81B 218M 2026-09
Bayer EUR 29.4B 2.87B 2026-09
BioCryst Pharmaceuticals USD 195.83M 13.02M 2026-09
Biogen USD 3.9B 18.7M 2026-09
BioMarin Pharmaceutical USD 1.6B 59.17M 2026-09
Emergent BioSolutions USD 651.3M 12.7M 2023-12
Gilead Sciences USD 12B 982M 2026-09
GlaxoSmithKline GBP 20.72B 814M 2026-09
Halozyme Therapeutics USD 476.09M 131.65M 2026-09
Insmed USD 596.57M 157.83M 2026-09
Ionis Pharmaceuticals USD 435.29M 119.65M 2026-09
J&J USD 55.46B 562M 2026-09
Lexicon Pharmaceuticals USD 9.9M 10.97M 2026-03
Moderna USD 2.03B 506M 2026-09
Omeros USD 85.5M 2.28M 2025-06
Pfizer USD 31.73B 920M 2026-09
PTC Therapeutics USD 776.08M 5.01M 2026-09
Regeneron Pharmaceuticals USD 6.2B 671.5M 2026-09
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sarepta Therapeutics USD 656.35M 153.44M 2026-09
Teva Pharmaceutical Industries USD 15.42B 221M 2026-09
United Therapeutics USD 624.3M 16.5M 2026-09
Vertex Pharmaceuticals USD 5B 1.06B 2026-09